Human β-defensin 2 (hBD-2) is a 41-amino acid cationic peptide of the innate immune system
that serves as antimicrobial molecule. We determined the bactericidal activity of synthetic …

… A fast bactericidal effect (within 20 min) against all bacterial strains tested was observed. The
… gram-negative strains and reduced the activity of the peptide against gram-positive strains. …

… the Center for Disease Control criteria for nosocomial pneumonia, urinary tract infection,
primary … of each strain was noted and only one strain per patient was included. The strains were …

… of human-defensin-2 against enteropathogens and nosocomial strains has been reported.
26… In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains. Peptides. …

… Clostridium difficile infection (CDI), one of the most common hospital-acquired infections, is
increasing in incidence and severity with the emergence and diffusion of hypervirulent strains…

… (PA) is a leading cause of nosocomial infections for which the fluoroquinolone antibiotics, for
… epithelial cells, and we compared strain α-defensin susceptibility to cytotoxic potential. For …

… As an opportunistic human pathogen, Staphylococcus strains have recently become the
most important cause of nosocomial infections and are one of the major pathogens in implant-…

… show antimicrobial activities against Gram-negative and Gram-positive bacterial strains
and … -resistant clinical isolates of common nosocomial pathogens, such as Staphylococcus …

… as β-defensins. This review provides a comprehensive analysis of the effects of β-defensins …
The lack of effective drugs for antimicrobial-resistant strains highlights the urgent need to …

… The strain adheres to A549 cell monolayers with the same efficiency when challenged at
28 C or 37 C, and stimulates innate immune responses releasing β defensin 2 and forming a …